Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis
- PMID: 29179576
- DOI: 10.1176/appi.ajp.2017.17020223
Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis
Erratum in
-
CORRECTION.Am J Psychiatry. 2019 Apr 1;176(4):324. doi: 10.1176/appi.ajp.2019.1764correction2. Am J Psychiatry. 2019. PMID: 30929503 No abstract available.
Abstract
Objective: The authors investigated the rates of conversion to schizophrenia and bipolar disorder after a substance-induced psychosis, as well as risk factors for conversion.
Method: All patient information was extracted from the Danish Civil Registration System and the Psychiatric Central Research Register. The study population included all persons who received a diagnosis of substance-induced psychosis between 1994 and 2014 (N=6,788); patients were followed until first occurrence of schizophrenia or bipolar disorder or until death, emigration, or August 2014. The Kaplan-Meier method was used to obtain cumulative probabilities for the conversion from a substance-induced psychosis to schizophrenia or bipolar disorder. Cox proportional hazards regression models were used to calculate hazard ratios for all covariates.
Results: Overall, 32.2% (95% CI=29.7-34.9) of patients with a substance-induced psychosis converted to either bipolar or schizophrenia-spectrum disorders. The highest conversion rate was found for cannabis-induced psychosis, with 47.4% (95% CI=42.7-52.3) converting to either schizophrenia or bipolar disorder. Young age was associated with a higher risk of converting to schizophrenia. Self-harm after a substance-induced psychosis was significantly linked to a higher risk of converting to both schizophrenia and bipolar disorder. Half the cases of conversion to schizophrenia occurred within 3.1 years after a substance-induced psychosis, and half the cases of conversion to bipolar disorder occurred within 4.4 years.
Conclusions: Substance-induced psychosis is strongly associated with the development of severe mental illness, and a long follow-up period is needed to identify the majority of cases.
Keywords: Alcohol Abuse; Mood Disorders-Bipolar; Psychoactive Substance Use Disorder; Psychosis; Schizophrenia.
Comment in
-
Substance-Induced Psychosis: An Indicator of Development of Primary Psychosis?Am J Psychiatry. 2018 Apr 1;175(4):303-304. doi: 10.1176/appi.ajp.2018.17121395. Am J Psychiatry. 2018. PMID: 29606066 No abstract available.
Similar articles
-
Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases.J Clin Psychiatry. 2013 Jan;74(1):e94-9. doi: 10.4088/JCP.12m07822. J Clin Psychiatry. 2013. PMID: 23419236
-
Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.Arch Gen Psychiatry. 2008 Nov;65(11):1269-74. doi: 10.1001/archpsyc.65.11.1269. Arch Gen Psychiatry. 2008. PMID: 18981338
-
Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder.Am J Psychiatry. 2023 Jun 1;180(6):437-444. doi: 10.1176/appi.ajp.22010076. Epub 2023 May 3. Am J Psychiatry. 2023. PMID: 37132221
-
Managing drug-induced psychosis.Int Rev Psychiatry. 2023 Aug-Sep;35(5-6):496-502. doi: 10.1080/09540261.2023.2261544. Epub 2024 Feb 1. Int Rev Psychiatry. 2023. PMID: 38299647 Review.
-
Cannabis use and psychotic disorders: an update.Drug Alcohol Rev. 2004 Dec;23(4):433-43. doi: 10.1080/09595230412331324554. Drug Alcohol Rev. 2004. PMID: 15763748 Review.
Cited by
-
Clinical Variables and Peripheral Biomarkers Associated with Substance-Induced Psychotic Disorder: Differences Related to Alcohol, Cannabis, and Psychostimulant Abuse.J Pers Med. 2024 Mar 21;14(3):325. doi: 10.3390/jpm14030325. J Pers Med. 2024. PMID: 38541067 Free PMC article.
-
Intensity of Psychoactive Substance Use Affects the Occurrence of Prodromal Symptoms of Psychosis.J Clin Med. 2024 Jan 28;13(3):760. doi: 10.3390/jcm13030760. J Clin Med. 2024. PMID: 38337454 Free PMC article.
-
Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use.Front Public Health. 2024 Jan 5;11:1268339. doi: 10.3389/fpubh.2023.1268339. eCollection 2023. Front Public Health. 2024. PMID: 38249418 Free PMC article.
-
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders.Neuropsychopharmacology. 2024 Mar;49(4):649-680. doi: 10.1038/s41386-023-01776-0. Epub 2023 Dec 12. Neuropsychopharmacology. 2024. PMID: 38086901 Free PMC article.
-
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.Front Psychiatry. 2023 Oct 3;14:1182536. doi: 10.3389/fpsyt.2023.1182536. eCollection 2023. Front Psychiatry. 2023. PMID: 37854446 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical